Share on StockTwits

CSL Limited (ASX:CSL) was upgraded by equities researchers at Deutsche Bank to a “buy” rating in a research report issued on Thursday. The firm currently has a $76.50 price target on the stock.

CSL Limited (ASX:CSL) traded down 0.32% on Thursday, hitting A$74.410. 2,000 shares of the company’s stock traded hands. CSL Limited has a one year low of A$63.770 and a one year high of A$75.130. The stock has a 50-day moving average of A$69.36 and a 200-day moving average of A$69.46. The company has a market cap of A$35.329 billion and a price-to-earnings ratio of 27.74.

A number of other analysts have also recently weighed in on CSL. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note on Thursday, August 21st. They now have a $74.55 price target on the stock. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of A$74.28 ($69.42).

CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.

Receive News & Ratings for CSL Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.